Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Verax Biomedical

Verax Biomedical

Verax is the producer of the Platelet PGD® Test, the only rapid test for bacterial contamination in platelets granted a Safety Measure claim by the FDA. The test can be used to extend the dating of apheresis platelets in plasma, the most common platelet type transfused in the U.S., from 5 to 7 days. This dating extension offers the opportunity for significant cost savings to the hospital and blood banking community while preserving a critical life-giving resource.

Last updated on

About Verax Biomedical

Founded

1999

Estimated Revenue

$1M-$10M

Employees

11-50

Funding / Mkt. Cap

$37M

Category

Industry

Biotechnology

Location

City

Marlborough

State

Massachusetts

Country

United States

Tech Stack (0)

search